Journal of Cancer Research and Clinical Oncology,
Journal Year:
2023,
Volume and Issue:
149(10), P. 7997 - 8006
Published: March 15, 2023
Artificial
intelligence
(AI)
is
influencing
our
society
on
many
levels
and
has
broad
implications
for
the
future
practice
of
hematology
oncology.
However,
medical
professionals
researchers,
it
often
remains
unclear
what
AI
can
cannot
do,
are
promising
areas
a
sensible
application
in
Finally,
limits
perils
using
oncology
not
obvious
to
healthcare
professionals.
Cancer Cell,
Journal Year:
2022,
Volume and Issue:
40(8), P. 865 - 878.e6
Published: Aug. 1, 2022
The
rapidly
emerging
field
of
computational
pathology
has
demonstrated
promise
in
developing
objective
prognostic
models
from
histology
images.
However,
most
are
either
based
on
or
genomics
alone
and
do
not
address
how
these
data
sources
can
be
integrated
to
develop
joint
image-omic
models.
Additionally,
identifying
explainable
morphological
molecular
descriptors
that
govern
such
prognosis
is
interest.
We
use
multimodal
deep
learning
jointly
examine
whole-slide
images
profile
14
cancer
types.
Our
weakly
supervised,
deep-learning
algorithm
able
fuse
heterogeneous
modalities
predict
outcomes
discover
features
correlate
with
poor
favorable
outcomes.
present
all
analyses
for
correlates
patient
across
the
types
at
both
a
disease
level
an
interactive
open-access
database
allow
further
exploration,
biomarker
discovery,
feature
assessment.
2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR),
Journal Year:
2022,
Volume and Issue:
unknown, P. 16123 - 16134
Published: June 1, 2022
Vision
Transformers
(ViTs)
and
their
multi-scale
hierarchical
variations
have
been
successful
at
capturing
image
representations
but
use
has
generally
studied
for
low-resolution
images
(e.g.
256
×
256,
384
384).
For
gigapixel
whole-slide
imaging
(WSI)
in
computational
pathology,
WSIs
can
be
as
large
150000
pixels
20
magnification
exhibit
a
structure
of
visual
tokens
across
varying
resolutions:
from
16
individual
cells,
to
4096
characterizing
interactions
within
the
tissue
microenvironment.
We
introduce
new
ViT
architecture
called
Hierarchical
Image
Pyramid
Transformer
(HIPT),
which
leverages
natural
inherent
using
two
levels
self-supervised
learning
learn
high-resolution
representations.
HIPT
is
pretrained
33
cancer
types
10,678
WSIs,
408,218
images,
104M
images.
benchmark
on
9
slide-level
tasks,
demonstrate
that:
1)
with
pretraining
outperforms
current
state-of-the-art
methods
subtyping
survival
prediction,
2)
ViTs
are
able
model
important
inductive
biases
about
phenotypes
tumor
Nature Communications,
Journal Year:
2021,
Volume and Issue:
12(1)
Published: July 20, 2021
The
Cancer
Genome
Atlas
(TCGA)
is
one
of
the
largest
biorepositories
digital
histology.
Deep
learning
(DL)
models
have
been
trained
on
TCGA
to
predict
numerous
features
directly
from
histology,
including
survival,
gene
expression
patterns,
and
driver
mutations.
However,
we
demonstrate
that
these
vary
substantially
across
tissue
submitting
sites
in
for
over
3,000
patients
with
six
cancer
subtypes.
Additionally,
show
histologic
image
differences
between
can
easily
be
identified
DL.
Site
detection
remains
possible
despite
commonly
used
color
normalization
augmentation
methods,
quantify
characteristics
constituting
this
site-specific
histology
signature.
We
signatures
lead
biased
accuracy
prediction
genomic
mutations,
tumor
stage.
Furthermore,
ethnicity
also
inferred
signatures,
which
must
accounted
ensure
equitable
application
These
overoptimistic
estimates
model
performance,
propose
a
quadratic
programming
method
abrogates
bias
by
ensuring
are
not
validated
samples
same
site.
Cancer Communications,
Journal Year:
2021,
Volume and Issue:
41(11), P. 1100 - 1115
Published: Oct. 6, 2021
Abstract
Over
the
past
decade,
artificial
intelligence
(AI)
has
contributed
substantially
to
resolution
of
various
medical
problems,
including
cancer.
Deep
learning
(DL),
a
subfield
AI,
is
characterized
by
its
ability
perform
automated
feature
extraction
and
great
power
in
assimilation
evaluation
large
amounts
complicated
data.
On
basis
quantity
data
novel
computational
technologies,
especially
DL,
been
applied
aspects
oncology
research
potential
enhance
cancer
diagnosis
treatment.
These
applications
range
from
early
detection,
diagnosis,
classification
grading,
molecular
characterization
tumors,
prediction
patient
outcomes
treatment
responses,
personalized
treatment,
automatic
radiotherapy
workflows,
anti‐cancer
drug
discovery,
clinical
trials.
In
this
review,
we
introduced
general
principle
summarized
major
areas
application
for
discussed
future
directions
remaining
challenges.
As
adoption
AI
use
increasing,
anticipate
arrival
AI‐powered
care.
Nature Medicine,
Journal Year:
2022,
Volume and Issue:
28(6), P. 1232 - 1239
Published: April 25, 2022
Abstract
Artificial
intelligence
(AI)
can
predict
the
presence
of
molecular
alterations
directly
from
routine
histopathology
slides.
However,
training
robust
AI
systems
requires
large
datasets
for
which
data
collection
faces
practical,
ethical
and
legal
obstacles.
These
obstacles
could
be
overcome
with
swarm
learning
(SL),
in
partners
jointly
train
models
while
avoiding
transfer
monopolistic
governance.
Here,
we
demonstrate
successful
use
SL
large,
multicentric
gigapixel
images
over
5,000
patients.
We
show
that
trained
using
BRAF
mutational
status
microsatellite
instability
hematoxylin
eosin
(H&E)-stained
pathology
slides
colorectal
cancer.
on
three
patient
cohorts
Northern
Ireland,
Germany
United
States,
validated
prediction
performance
two
independent
Kingdom.
Our
SL-trained
outperform
most
locally
models,
perform
par
are
merged
datasets.
In
addition,
SL-based
efficient.
future,
used
to
distributed
any
image
analysis
task,
eliminating
need
transfer.